Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nov 30 versus Dec 3
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"Revenue from our technology license agreements is generally recognized at the time we enter into a contract and provide our customer with the licensed technology."

That's the language from PTSC's SEC filings, so PTSC books the revenue upon the signing of the contract.

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply